The Limulus Amebocyte Lysate (LAL) assay is the gold standard for detecting bacterial endotoxins. In the pharmaceutical industry, the presence of these pyrogens in parenteral drugs or medical devices can trigger severe physiological reactions, including fever, inflammation, and potentially fatal hypotensive shock. Since its formal adoption, the LAL test has largely replaced the rabbit pyrogen test due to its superior sensitivity, being up to 300 times more effective at identifying minute contaminants. At Creative Biolabs, we provide standardized kits that translate this natural biological response into a high-precision diagnostic tool for modern biomanufacturing.
Fig.1 The innate immunity is stimulated by bacterial endotoxins (LPS).1
The LAL assay mimics the primitive immune response of the horseshoe crab (Limulus polyphemus). When endotoxins are introduced to the amebocyte lysate, they trigger a sophisticated enzymatic cascade.
At Creative Biolabs, we provide an extensive selection of testing formats engineered to accommodate diverse sample types, throughput requirements, and sensitivity levels. Our portfolio ranges from traditional qualitative screening to high-precision, automated quantitative analysis.
This is the standard assay for end-product testing of parenteral drugs and medical devices. It is available in standardized sensitivities to confirm if endotoxin levels are below the required limit.
This version is optimized for accelerated turnaround times, making it suitable for in-process monitoring where rapid feedback is required without compromising the integrity of the clot formation.
Specifically designed for applications where sample volume is highly limited. It utilizes miniaturized reaction volumes to conserve precious materials, such as rare antibodies or small-scale protein batches.
Features pre-measured, lyophilized lysate within a vacuum-sealed environment. This design streamlines direct sampling workflows and significantly reduces the risk of extraneous environmental contamination during the reconstitution process.
This assay measures the release of a yellow color signal as the enzymatic cascade cleaves a synthetic substrate. It is highly sensitive and is the preferred choice for vaccines and biologics that might physically interfere with gel formation.
This method measures the rate of turbidity increase as the gelation protein precipitates. It provides a sensitive quantitative alternative for samples that have intrinsic color which might interfere with chromogenic readings.
Combines the high sensitivity of chromogenic detection with micro-volume reagent use. This kit is ideal for laboratories processing high volumes of samples who wish to maximize efficiency and minimize cost per test.
Developed for laboratories that prefer tube-based quantitative workflows for individual sample handling. It is particularly useful for validating complex biotherapeutic drugs where each batch requires precise, individual oversight.
Specifically optimized for high-throughput testing of complex matrices (e.g., serum, vaccines, or antivenoms). These kits are pre-configured with specialized buffers to block beta-glucan interference and include dispersing agents to prevent endotoxin from adhering to plastic surfaces.
Creative Biolabs provides the most comprehensive array of LAL Assay Kits designed to meet the rigorous safety demands of the modern biopharmaceutical industry. From traditional Gel Clot formats to high-sensitivity kinetic systems, our products ensure that your parenteral drugs and medical devices are free from pyrogenic contamination and fully compliant with international regulations. Contact us for your projects.
Reference